openPR Logo
Press release

Acute Pancreatitis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | JD BIOSCIENCE, Cypralis, Regeneron Pharmaceuticals, SCM Lifescience, HighTide Therapeutics, CalciMedica, Lamassu Pharma LLC

08-11-2023 06:09 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Acute Pancreatitis Pipeline Assessment (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Acute Pancreatitis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Acute Pancreatitis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acute Pancreatitis Therapeutics Market.

The report provides a detailed description of the Acute Pancreatitis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Acute Pancreatitis Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/acute-pancreatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Pancreatitis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Acute Pancreatitis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Pancreatitis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Acute Pancreatitis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Acute Pancreatitis treatment market.

Learn More about the Clinical and Commercial Development Activities in the Acute Pancreatitis Therapeutics Domain:
https://www.delveinsight.com/report-store/acute-pancreatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Acute Pancreatitis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Route of Administration
Acute pancreatitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous

Molecule Type
Products have been categorized under various Molecule types such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine

Request for Sample PDF to Understand More About the Acute Pancreatitis Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/acute-pancreatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Pancreatitis Therapeutics Analysis
The management of acute pancreatitis depends on the severity of the disease and the concomitant complications that may arise. The treatment approach is usually based on the extent of severity and the underlying cause of the disease. The primary goal of the treatment is to relieve the pain and reduce the inflammation associated with the Pancreas. Currently, there is no therapy that is approved by the FDA to treat Acute Pancreatitis, therefore the treatment generally focuses on relieving the symptoms of pain, inflammation, and any underlying complications that arise due to it.

Several major pharma and biotech companies are developing therapies for Acute pancreatitis. Currently, CalciMedica Inc. is leading the therapeutics market with its Acute pancreatitis drug candidates in the most advanced stage of clinical development.

Acute Pancreatitis Companies in the Therapeutics Market Include:
• JD BIOSCIENCE
• Cypralis
• Regeneron Pharmaceuticals
• SCM Lifescience
• HighTide Therapeutics
• CalciMedica Inc.
• Lamassu Pharma LLC
And Many Others

Emerging and Marketed Acute Pancreatitis Therapies Covered in the Report Include:
• Auxora: CalciMedica Inc.
• REGN1500: Regeneron Pharmaceuticals
• RABI-767: Lamassu Pharma LLC
And Many Other

Get an in-depth Assessment of the Emerging Therapies and Acute Pancreatitis Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/acute-pancreatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Acute Pancreatitis Current Treatment Patterns
4. Acute Pancreatitis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acute Pancreatitis Late-Stage Products (Phase-III)
7. Acute Pancreatitis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acute Pancreatitis Discontinued Products
13. Acute Pancreatitis Product Profiles
14. Acute Pancreatitis Companies
15. Acute Pancreatitis Drugs
16. Dormant and Discontinued Products
17. Acute Pancreatitis Unmet Needs
18. Acute Pancreatitis Future Perspectives
19. Acute Pancreatitis Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/acute-pancreatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Erectile Dysfunction Market
https://www.delveinsight.com/report-store/erectile-dysfunction-market

Varicose Ulcer Market
https://www.delveinsight.com/report-store/varicose-ulcer-market

Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor Pipeline Insight
https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight

Stereotactic Surgery Devices Market
https://www.delveinsight.com/report-store/stereotactic-surgery-devices-market

Acute lymphocytic leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphocytic-leukemia-all-market

Eczema Market
https://www.delveinsight.com/report-store/eczema-market

Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market

Hemostats Market
https://www.delveinsight.com/report-store/hemostats-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Peripheral Vascular Devices Market
https://www.delveinsight.com/report-store/peripheral-vascular-devices-market

Obesity Market
https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market

Urinary Incontinence Market
https://www.delveinsight.com/report-store/urinary-incontinence-market

Hemostasis Market
https://www.delveinsight.com/report-store/hemostasis-market

Intracardiac Echocardiography Devices Market
https://www.delveinsight.com/report-store/intracardiac-echocardiography-devices-market

Emphysema Market
https://www.delveinsight.com/report-store/emphysema-market

Hairy Cell Leukemia (HCL) Market
https://www.delveinsight.com/report-store/hairy-cell-leukemia-hcl-market

Cancer Cachexia (CC) Market
https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights

Diabetes Market
https://www.delveinsight.com/report-store/diabetes-market

Panuveitis Market
https://www.delveinsight.com/report-store/panuveitis-market

Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market

mRNA Vaccine and Therapeutics Market
https://www.delveinsight.com/report-store/mrna-vaccine-and-therapeutics-market

Negative Pressure Wound Therapy Systems Market
https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market

Hematuria Market
https://www.delveinsight.com/report-store/hematuria-market

Smart Inhalers Market
https://www.delveinsight.com/report-store/smart-inhalers-market

Audiology Devices Market
https://www.delveinsight.com/report-store/audiology-devices-market

Deep Brain Stimulation Devices Market
https://www.delveinsight.com/report-store/deep-brain-stimulation-devices-market

Prosthetic Heart Valve Market
https://www.delveinsight.com/report-store/prosthetic-heart-valve-market

Tongue Cancer Market
https://www.delveinsight.com/report-store/tongue-cancer-market

Cancer Vaccines Market
https://www.delveinsight.com/report-store/cancer-vaccines-market

CAR-T Pipeline Insight
https://www.delveinsight.com/report-store/car-t-pipeline-insight

Concussions Market
https://www.delveinsight.com/report-store/concussions-market

Total Knee Arthroplasty Market
https://www.delveinsight.com/report-store/total-knee-arthroplasty-market

Physiotherapy Equipment Market
https://www.delveinsight.com/report-store/physiotherapy-equipment-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

Persistent Depressive Disorder Market
https://www.delveinsight.com/report-store/persistent-depressive-disorder-market

Anti-hypertension Market
https://www.delveinsight.com/report-store/anti-hypertension-market

Seborrhoeic Dermatitis Market
https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market

Spirometers Market
https://www.delveinsight.com/report-store/spirometers-market

Tumor Ablation Market
https://www.delveinsight.com/report-store/tumor-ablation-market

Migraine Market
https://www.delveinsight.com/report-store/migraine-market

Pegfilgrastim Biosimilar
https://www.delveinsight.com/report-store/pegfilgrastim-biosimilar-insight

Renal Vasculitis Market
https://www.delveinsight.com/report-store/renal-vasculitis-market

Dense Deposit Disease Market
https://www.delveinsight.com/report-store/dense-deposit-disease-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Pancreatitis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | JD BIOSCIENCE, Cypralis, Regeneron Pharmaceuticals, SCM Lifescience, HighTide Therapeutics, CalciMedica, Lamassu Pharma LLC here

News-ID: 3163302 • Views:

More Releases from DelveInsight Business Research LLP

Gene Therapies for Cardiomyopathies Market to Witness Growth by 2032 | Adverum Biotechnologies, Bluebird bio, CRISPR Therapeutics, Editas Medicine, MeiraGTx, Rocket Pharmaceuticals, Sarepta Therapeutics, Vertex Pharmaceuticals
Gene Therapies for Cardiomyopathies Market to Witness Growth by 2032 | Adverum B …
DelveInsight's "Gene Therapies for Cardiomyopathies Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gene Therapies for Cardiomyopathies, historical and forecasted epidemiology as well as the Gene Therapies for Cardiomyopathies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene Therapies for Cardiomyopathies market report provides current treatment practices, emerging drugs, Gene Therapies for Cardiomyopathies market share of the
Chronic Fatigue Syndrome Market to Witness Growth by 2032 | AIM Immunotech, Cortene, NLS Pharmaceutics
Chronic Fatigue Syndrome Market to Witness Growth by 2032 | AIM Immunotech, Cort …
DelveInsight's "Chronic Fatigue Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Fatigue Syndrome, historical and forecasted epidemiology as well as the Chronic Fatigue Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Fatigue Syndrome market report provides current treatment practices, emerging drugs, Chronic Fatigue Syndrome market share of the individual therapies, and current and
Cognitive Impairment Associated with Schizophrenia Market to Witness Growth by 2032 | Boehringer Ingelheim International, Pfizer and INVENT Pharmaceuticals
Cognitive Impairment Associated with Schizophrenia Market to Witness Growth by 2 …
DelveInsight's "Cognitive Impairment Associated with Schizophrenia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Cognitive Impairment Associated with Schizophrenia, historical and forecasted epidemiology as well as the Cognitive Impairment Associated with Schizophrenia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cognitive Impairment Associated with Schizophrenia market report provides current treatment practices, emerging drugs, Cognitive Impairment Associated with
Spinocerebellar Ataxias Market to Witness Growth by 2032 | Seelos Therapeutics Inc., Biogen, Kissei Pharmaceuticals Co. Ltd, HLB Pharmaceuticals Co. Ltd, Baxter Healthcare Corporation, Biohaven Pharmaceuticals, Acorda Therapeutics
Spinocerebellar Ataxias Market to Witness Growth by 2032 | Seelos Therapeutics I …
DelveInsight's "Spinocerebellar Ataxias Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Spinocerebellar Ataxias, historical and forecasted epidemiology as well as the Spinocerebellar Ataxias market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Spinocerebellar Ataxias market report provides current treatment practices, emerging drugs, Spinocerebellar Ataxias market share of the individual therapies, and current and forecasted Spinocerebellar Ataxias market size

All 5 Releases


More Releases for Acute

Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Pipeline Review, H2 2017 of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic …
"Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Acute Renal Failure (ARF) (Acute Kidney Injury) Market: Industry Size, Share, Gr …
Latest industry research report on: Acute Renal Failure (ARF) (Acute Kidney Injury) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2017, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Request For Sample Report
Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H2
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1230595 Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood.
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth